Today we will talk about topics such as:
- Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine among elderly and frail patients with advanced esophageal cancer: the randomized phase 3 GO2 clinical trial.
- The addition of atezolizumab to bevacizumab and chemotherapy improves treatment outcomes for metastatic cervical cancer.
News is available at <--/noindex-->link
.
The author of the column is Merkulov Igor Aleksandrovich, oncologist, deputy chief physician for oncology at the K+31 West clinic . You can always ask Igor Alexandrovich a question, or get his online consultation.